Announcing SHARE’s National Expansion

New Support Groups Active in Norwalk, CT; Brentwood, NY; and Orlando, FL
After 42 years in New York City, SHARE Cancer Support has announced a national expansion effort. Norwalk, CT; Brentwood, Long Island, NY; and Orlando, FL are the first cities outside New York City to offer SHARE’s in-person services to women with breast or ovarian cancers.

Introducing new program formats!

If you receive our program calendar or email newsletter, you may have noticed some new types of educational programs. In addition to our webinars and in-person programs, we are now offering interactive educational opportunities through other platforms. These new kinds of programs offer the same quality content, and make it easy for you to engage with the presenters.

Treating Endocrine-Resistant Metastatic Breast Cancer

In September, the FDA approved amebaciclib (Verzenio), the latest drug to treat endocrine resistant metastatic breast cancer (MBC). In combination with fulvestrant (Faslodex), the results of the phase III, Monarch 2 trial showed an improvement in progression free survival (PFS). All the patients in the trial were hormone receptor positive and HER2 negative, as are all the enrollees in the trials noted here.

Update on TAPUR Study

At its annual meeting this year in June, the American Society of Clinical Oncology (ASCO) gave patient advocates an update on the TAPUR clinical trial, which is its first trial. The trial was rolled out about two years ago.

The TAPUR trial (Targeted Agent and Profiling Utilization Registry) allows us to obtain FDA-approved drugs free-of-charge by cutting out the red tape when we are no longer benefiting from any standard treatment.

Financial Toxicity and Cancer

This post was written by Teri Pollastro.

Over the last several years we have heard about precision medicine, payment reform and patient-centered care. While I was at ASCO this year, I heard a new buzz word; financial toxicity. The phenomenon of financial toxicity has been whispered about for years.

Young Professionals Support Pink and Teal!

Jordan Donohue of CBRE, Inc., and Ally Goldman of WB Wood, hosted a kickoff event last week at Madison Square Tavern for the SHARE Pink and Teal Young Professionals Group! The group is enlisting young professionals in New York City's Design/Construction/Real Estate industries to support SHARE's work in educating corporate employees about breast and ovarian cancers.

Announcing New Online Support Offerings

SHARE is excited to announce its partnership with HealthUnlocked, the social network for health!
There are 2.8 million women with a history of breast cancer in the U.S. (including 155,000 women living with metastatic breast cancer), and approximately 195,000 with ovarian cancer in the United States alone.

The Status of Liquid Biopsies in Metastatic Cancer

This article was written by Joan Mancuso.

As a woman living with metastatic breast cancer, I’ve always dreaded getting a tissue biopsy of a metastasis. Even though the biopsy yields information about the tumor’s pathology and potentially affects my treatment options, I consider it a necessary evil.

National Helpline: